Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_assertion type Assertion NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_head.
- NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_provenance.
- NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_assertion evidence source_evidence_literature NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_provenance.
- NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_assertion SIO_000772 20204404 NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_provenance.
- NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_assertion wasDerivedFrom befree-20150227 NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_provenance.
- NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_assertion wasGeneratedBy ECO_0000203 NP624327.RAn6_SfaeSPwmaFSdr3kQ92Df0F-9Qg-NtKvNDBgcLD5g130_provenance.